Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Directorate Change

30 Aug 2024 07:00

RNS Number : 2257C
Computacenter PLC
30 August 2024
 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

Computacenter plc

Directorate Change

Computacenter plc ("Computacenter" or the "Company"), a leading independent technology and services provider, is pleased to announce the appointment of Adam Walker as an independent Non-Executive Director of its Board of Directors (the "Board"), Chair of the Company's Audit Committee, and member of the Company's Nomination and Remuneration Committees, with immediate effect. 

On 30 September 2024, Adam will also become Senior Independent Director of the Company when, as previously announced, Dr Ros Rivaz will step down from that role and from the Board.

Adam is currently a Non-Executive Director of Currys plc, and a member of its Audit and Remuneration Committees. His former executive roles include Executive Vice President and Chief Financial Officer of IHS Holding Limited from 2017 to 2022, Chief Financial Officer of GKN plc, Group Finance Director at Informa PLC, and Finance Director at National Express Group PLC. Adam was a Non-Executive Director and Chair of the Audit Committee at Kier Group plc from 2016 to 2019, and a Non-Executive Director and Chair of the Audit Committee at Tritium DCFC Limited, listed on Nasdaq, until April 2024.

Pauline Campbell, Chair of the Board, commented:

"I would like to welcome Adam to Computacenter. The Board will benefit significantly from his wealth of financial experience and expertise, which he brings following a successful and varied executive career serving as the CFO of multinational listed companies for over 20 years."

Note:

This announcement is made pursuant to Listing Rule 6.4.6. In accordance with LR 6.4.8 of the Listing Rules, Computacenter confirms that there is no information to be disclosed in terms of LR 6.4.8R (2) to LR 6.4.8R (6) inclusive in respect of Adam Walker.

Enquiries:

Computacenter plc

 

Mike Norris, CEO

+44 (0) 1707 631 601

Chris Jehle, CFO

+44 (0) 1707 631 515

Christian Cowley, Investor Relations

+44 (0) 1707 631 132

Teneo

 

James Macey White / Matt Low

+44 (0) 2073 534 200

 

 

 

About Computacenter:

Computacenter is a leading independent technology and services provider, trusted by large corporate and public sector organisations. We are a responsible business that believes in winning together for our people and our planet. We help our customers to Source, Transform and Manage their technology infrastructure to deliver digital transformation, enabling people and their business. Computacenter plc is a public company quoted on the London Stock Exchange (CCC.L) and a member of FTSE 250. Computacenter employs over 20,000 people worldwide.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUKABRSOUWUAR
Date   Source Headline
2nd Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSQ3 2022 Trading Update
20th Oct 202210:30 amRNSDirectorate Change
27th Sep 202212:00 pmRNSHolding(s) in Company
22nd Sep 202210:30 amRNSDirector/PDMR Shareholding
12th Sep 202212:00 pmRNSDirector/PDMR Shareholding
9th Sep 20227:00 amRNSHalf-year Report
5th Aug 20229:30 amRNSBlock listing Interim Review
13th Jul 20227:00 amRNSAcquisition
19th May 20221:30 pmRNSResult of AGM
9th May 20225:30 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSQ1 2022 Trading Update
27th Apr 20229:03 amRNSCarbon Neutral Announcement
13th Apr 202212:15 pmRNS2021 Annual Financial Report & Notice of 2022 AGM
23rd Mar 20224:45 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results 2021
7th Feb 20229:49 amRNSBlock listing Interim Review
24th Jan 20227:00 amRNSPre-Close Trading Statement
12th Jan 20229:45 amRNSHolding(s) in Company
14th Dec 20214:45 pmRNSHolding(s) in Company
13th Dec 20215:00 pmRNSHolding(s) in Company
10th Dec 20212:00 pmRNSCompany Secretary Change
2nd Dec 20212:45 pmRNSDirector/PDMR Shareholding
15th Nov 202112:15 pmRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSQ3 2021 Trading Update
30th Sep 202112:00 pmRNSDirectorate Change
15th Sep 20214:25 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSTrading Statement
12th Aug 202112:00 pmRNSDirector Declaration
6th Aug 202111:15 amRNSBlock listing Interim Review
21st Jul 20217:00 amRNSTrading Statement
20th May 20211:00 pmRNSResult of AGM
30th Apr 20217:00 amRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSQ1 2021 Trading Update
20th Apr 20217:00 amRNS2020 Annual Report & Notice of 2021 AGM
24th Mar 20212:00 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSFinal Results 2020
10th Mar 20217:00 amRNSDirectorate Change
5th Feb 20211:18 pmRNSBlock listing Interim Review
25th Jan 202111:45 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSPre-Close Trading Statement
4th Jan 20211:00 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSTrading Statement
10th Nov 20204:00 pmRNSPDMR/PCA Shareholding
30th Oct 20207:00 amRNSQ3 2020 Trading Update
27th Oct 20209:30 amRNSDirector/PDMR Shareholding
23rd Oct 20205:45 pmRNSApproval of Arrangement Agreement
16th Sep 202012:45 pmRNSDirector/PDMR Shareholding
15th Sep 20201:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.